- Niowave’s $75M radioisotope facility; CordenPharma to buy AmbioPharmPlus, news about Agilent’s earnings report: ☢️ Niowave’s radioisotope factory: The company has broken ground on a $75 million production facility in Lansing, MI, which will be used to manufacture…Endpoints · 1mo ago↗ source
- Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapyThree months ago, Charles River Laboratories announced it would shed its manufacturing unit, which has a focus on cell and gene therapies. And, according to its CEO Birgit Girshick, other companies…Endpoints · 1mo ago↗ source
- China gene editing startup YolTech raises $70M to move CRISPR therapies forwardOne of China’s most prolific gene editing companies has raised its biggest round of funding yet, ahead of plans to go public in Hong Kong. While most gene editing companies in the US trimmed their…